`risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in korea

HIGHLIGHTS

• who: Hoon Jeong from the Office of Pharmacoepidemiology and Bigdata Analytics, Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, th FL, Burimu2011ro, beonu2011gil, Donganu2011gu, Anyangu2011si, Gyeonggiu2011do, Republic of Korea have published the research: `Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea, in the Journal: Rheumatology International (2023) 43:265-281 of June/30,/2018
• what: The study aimed to comparatively analyze the risk of cardiovascular disease associated with febuxostat and allopurinol use in Korean patients with gout. Despite . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.